
32.70 Delayed Data As of Sep 22 | ![]() Today’s Change | 32.50 Today|||52-Week Range 54.93 | -36.19% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $192.4B |
Pfizer Inc. 66 Hudson Boulevard East New York New York 10001-2192 |
Albert Bourla | Chairman & Chief Executive Officer |
David M. Denton | Chief Financial Officer & Executive Vice President |
Annaliesa Anderson | SVP, Head-Vaccine Research & Development |
Mikael Dolsten | Co-Chief Scientific Officer & President-Research |
Jeff Settleman | Co-Chief Scientific Officer |